News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Jeff Molter: NYU Langone Health’s Perlmutter Cancer Center has been re-designated by NCI
Photo from Jeff Molter/LinkedIn
May 1, 2024, 09:18

Jeff Molter: NYU Langone Health’s Perlmutter Cancer Center has been re-designated by NCI

Jeff Molter, Director of NYU Langone Health, posted on LinkedIn:

“NYU Langone Health’s Perlmutter Cancer Center has been re-designated by the National Cancer Institute (NCI) as a comprehensive cancer center.”

Image preview

View the article attached to the post.
Source: Jeff Molter/LinkedIn

cancer Jeff Molter National Cancer Institute NCI NYU Langone Health's Perlmutter Cancer Center OncoDaily Oncology
Special Coverage
Insight
Apr 3, 2025, 16:37
OncoBillionaires of 2025: The Titans Behind the Cancer Revolution
Blog
Apr 3, 2025, 16:09
Low-dose CT Scans Identify 80% of Early Lung Cancers in High-Risk Groups - Lung Cancer Europe
Blog
Apr 3, 2025, 16:04
Zainab Shinkafi-Bagudu: How creativity fuels advocacy
Blog
Apr 3, 2025, 15:12
The Advances in Cancer Immunotherapy - SITC
Science
Apr 3, 2025, 15:00
Jeff Ryckman: Fascinating results for neoadjuvant Aumolertinib in EGFR-Mutant NSCLC
Insight
Apr 3, 2025, 14:43
Turkey's two largest cities are stepping up to prevent HPV cancers among their residents - CancerWorld
Dialogues
Apr 3, 2025, 14:39
The Comfort Corner #5: Dialogue with Joanne Bowen, hosted by Martin Harutyunyan
Blog
Apr 3, 2025, 14:33
Benjamin Ebert: Thank you to everyone who attended the celebration of the Dana-Farber Campaign
Blog
Apr 3, 2025, 14:23
Roni Shouval: Proud of Magdalena Corona for receiving the Jian-Jian Luan Award
Insight
Apr 3, 2025, 14:17
Study links prolactin levels to breast cancer risk in post-menopausal women - ICR
Blog
Apr 3, 2025, 13:58
Join Mehran Karimi at the 7th Emirates Pediatric Hematology and Oncology Conference - MENA Conference
Blog
Apr 3, 2025, 13:58
Ignacio Garrido-Laguna: Dosing first patient in the world with BBO-11818, a novel PanKras inhibitor